Patient-reported outcomes among people receiving opioid agonist therapy and treatment for hepatitis C virus infection: results from CO-STAR

MLA

Olav Dalgard, et al. “Patient-Reported Outcomes among People Receiving Opioid Agonist Therapy and Treatment for Hepatitis C Virus Infection: Results from CO-STAR.” Journal of Hepatology, vol. 73, Aug. 2020, p. S356. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........80d885c86f332ac4c8c2b1242e8eda01&authtype=sso&custid=ns315887.

APA

Olav Dalgard, Alain Litwin, Gregory Dore, Oren Shibolet, Jason Grebely, Ronald Nahass, Frederick Altice, Brian Conway, Edward Gane, Anne Luetkemeyer, Cheng-Yuan Peng, David Iser, Isaias Noel Gendrano, Michelle M. Kelly, Barbara Haber, Heather Loryn Platt, & Amy Puenpatom. (2020). Patient-reported outcomes among people receiving opioid agonist therapy and treatment for hepatitis C virus infection: results from CO-STAR. Journal of Hepatology, 73, S356.

Chicago

Olav Dalgard, Alain Litwin, Gregory Dore, Oren Shibolet, Jason Grebely, Ronald Nahass, Frederick Altice, et al. 2020. “Patient-Reported Outcomes among People Receiving Opioid Agonist Therapy and Treatment for Hepatitis C Virus Infection: Results from CO-STAR.” Journal of Hepatology 73 (August): S356. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........80d885c86f332ac4c8c2b1242e8eda01&authtype=sso&custid=ns315887.